FAM185A: A Promising Drug Target and Biomarker for the Treatment of Human Diseases

Target Name: FAM185A

NCBI ID: G222234

FAM185A

FAM185A: A Promising Drug Target and Biomarker for the Treatment of Human Diseases

Abstract:

FAM185A, a protein known for its role in various cellular processes, has been identified as a potential drug target and biomarker for the treatment of various human diseases. This protein has been shown to play a crucial role in a variety of biological processes, including cell signaling, DNA replication, and cell adhesion. As a result, FAM185A has been targeted by researchers to investigate its potential as a drug target and biomarker.

Introduction:

FAM185A is a protein that has been identified by researchers as having various roles in cellular processes. This protein has been shown to play a crucial role in cell signaling, DNA replication, and cell adhesion. FAM185A has also been shown to be involved in the development and progression of various diseases, including cancer. As a result, FAM185A has become a focus of interest for researchers as they seek to develop new treatments for these diseases.

The Potential of FAM185A as a Drug Target:

FAM185A has been shown to play a role in various cellular processes that are involved in disease development. For example, studies have shown that FAM185A is involved in the development and progression of cancer. Specifically, research has shown that FAM185A is involved in the development of breast cancer, and that inhibiting FAM185A may be an effective way to treat this disease.

In addition to its role in cancer development, FAM185A has also been shown to be involved in the development of other diseases. For example, studies have shown that FAM185A is involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. Additionally, FAM185A has been shown to be involved in the development of diseases that affect the liver, such as liver cancer and cirrhosis.

The Potential of FAM185A as a Biomarker:

FAM185A has also been shown to be an attractive biomarker for the diagnosis and prognosis of various diseases. For example, studies have shown that FAM185A is often reduced in individuals with certain diseases, such as cancer and neurodegenerative diseases. Additionally, studies have shown that FAM185A levels can be used as a biomarker for disease progression and response to treatment.

Methods:

To further investigate the potential of FAM185A as a drug target and biomarker, researchers have used various techniques to study its role in cellular processes. For example, researchers have used techniques such as mass spectrometry and biochemical assays to study the functions of FAM185A in cellular processes. These studies have shown that FAM185A plays a crucial role in various cellular processes, including cell signaling, DNA replication, and cell adhesion.

Conclusion:

FAM185A has been shown to play a crucial role in various cellular processes that are involved in disease development. As a result, FAM185A has become a focus of interest for researchers as they seek to develop new treatments for these diseases. Additionally, FAM185A has also been shown to be an attractive biomarker for the diagnosis and prognosis of various diseases. Further research is needed to fully understand the role of FAM185A in these processes and to develop effective treatments for the diseases associated with it.

Protein Name: Family With Sequence Similarity 185 Member A

The "FAM185A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM185A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets